Form 4: Equillium Director Peter Colabuono Granted 20,000 Stock Options

Equillium, Inc. Director Peter Colabuono was granted 20,000 stock options with an exercise price of $0.39, vesting over twelve months or until the next annual stockholder meeting.

Summary

• Peter Colabuono, a Director of Equillium, Inc. (EQ), was granted 20,000 Director Stock Options.
• The options have an exercise price of $0.39 per share.
• The grant date for these options was May 21, 2025.
• The options will vest in twelve equal monthly installments commencing from the grant date.
• The options will be fully vested on the date of Equillium's annual meeting of stockholders following the grant date.
• The expiration date for these options is May 20, 2035.
• Following this transaction, Peter Colabuono beneficially owns 20,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a routine compensation event that aligns management's interests with shareholders, generally viewed as a neutral to slightly positive development for corporate governance and incentive alignment.

Positives

• The grant of 20,000 stock options to Director Peter Colabuono aligns his interests with shareholders by incentivizing future stock price appreciation.
• The exercise price of $0.39 per share provides a clear target for value creation.

Future Outlook

The granted stock options are set to vest over the next twelve months or until the company's next annual stockholder meeting, providing a future incentive for the director's performance and alignment with shareholder value.

Industry Context

This Form 4 filing details an insider transaction specific to Equillium, Inc. and does not provide broader industry context or trends, as it is a routine disclosure of an individual's equity compensation.

Related Party Transactions

• The grant of 20,000 Director Stock Options to Peter Colabuono, a Director of Equillium, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant of stock options to a director aims to align their interests with shareholders by incentivizing stock price appreciation and long-term value creation.

Next Steps

• The granted stock options will vest in twelve equal monthly installments commencing May 21, 2025.
• The options will fully vest on the date of the Issuer's annual meeting of stockholders following the grant date.

Key Dates

Keywords

Equillium, EQ, Stock Option, Director, Peter Colabuono, SEC Form 4, Insider Transaction, Equity Grant